Proton pump inhibitor and histamine-2 receptor antagonist use and risk of liver cancer in two population-based studies. (2018)

First Author: Tran KT

Attributed to: UK Biobank (core renewal) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/apt.14796

PubMed Identifier: 29741272

Publication URI: http://europepmc.org/abstract/MED/29741272

Type: Journal Article/Review

Volume: 48

Parent Publication: Alimentary pharmacology & therapeutics

Issue: 1

ISSN: 0269-2813